Matthew B. Harms, MD

Associate professor of neurology, Columbia University; Medical consultant and care center director, Muscular Dystrophy Association

Articles

Advocacy’s Part in the Progress in ALS: Matthew B. Harms, MD

May 16, 2022

In light of ALS Awareness Month, the associate professor of neurology at Columbia University discussed the ways in which advocacy has provided a platform for patients and improved conversations in care. [WATCH TIME: 6 minutes]

The Role of Genetics and Database Variety for ALS Research: Matthew B. Harms, MD

May 13, 2022

The associate professor of neurology at Columbia University discussed the role of genetics in ALS and how it compares to other neurodegenerative disorders, as well as why having a variety of large databases will prove positive for the field. [WATCH TIME: 4 minutes]

Laying the Foundation in ALS Research: Matthew B. Harms, MD

May 12, 2022

The associate professor of neurology at Columbia University spoke to the recent progress made in ALS research and how the neuromuscular field has pushed the envelope to improve care and develop a cure for the disease. [WATCH TIME: 4 minutes]

Patient Conversations About Clinical Development in ALS: Matthew B. Harms, MD

May 10, 2021

The associate professor of neurology at Columbia University and medical consultant and care center director at the Muscular Dystrophy Association spoke to the importance of staying up on the latest developments in ALS and keeping patients in the loop on that information.

The Impact of Big Data on ALS Care: Matthew B. Harms, MD

May 09, 2021

The associate professor of neurology at Columbia University and medical consultant and care center director at the Muscular Dystrophy Association discussed the use of larger datasets to improve prognostication and clinical trials in ALS.

The Importance of ALS Awareness Month: Matthew B. Harms, MD

May 06, 2021

The associate professor of neurology at Columbia University and medical consultant and care center director, Muscular Dystrophy Association, discusses the impact that the Ice Bucket Challenge and ALS Awareness Month have had on the ALS treatment landscape.